IMNN
IMNN clinical trials: Imunon, Inc.
Every trial on ClinicalTrials.gov where Imunon, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 17
- Trials linked
- 15
- As lead sponsor
- 2
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
IMNN on the catalyst calendar · IMNN registry changes
- Primary completion Oct 31, 2032Sponsor estimatePhase 3NCT06915025Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly...Imunon · Epithelial Ovarian CancerRecruitingIMNNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2027Sponsor estimatePhase 1/Phase 2NCT05739981Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal...Imunon · Ovarian CancerRecruitingIMNNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 25, 2024ActualPhase 1/Phase 2NCT03393884Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)Imunon · Epithelial Ovarian CancerActive, not recruitingIMNNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 7, 2025ActualPhase 1/Phase 2NCT06283459Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2Imunon · SARS CoV 2 InfectionCompletedIMNNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2017ActualPhase 1NCT02480374Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian CancerImunon · Epithelial Ovarian CancerCompletedIMNNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 27, 2020ActualPhase 3NCT02112656Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)Imunon · Hepatocellular CarcinomaCompletedIMNNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2013ActualPhase 3NCT00617981Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)Imunon · Hepatocellular CarcinomaCompletedIMNNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2013ActualPhase 2NCT01464593Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)Imunon · Colon Cancer Liver MetastasisTerminatedIMNNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2019Sponsor estimatePhase 2NCT02850419Heat-Activated Target Therapy of Local-Regional Relapse in Breast Cancer PatientsImunon · Breast CancerWithdrawnIMNNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2008ActualPhase 1NCT00441376A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the LiverImunon · Hepatocellular CarcinomaCompletedIMNNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2013ActualPhase 2NCT01640847MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone MetastasesImunon · Painful Bone MetastasesWithdrawnIMNNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2015ActualPhase 1/Phase 2NCT00826085Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest WallImunon · Breast CancerCompletedIMNNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 2NCT00036985Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast CancerImunon · Breast CancerUnknown statusIMNNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 2NCT00036998Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast CancerImunon · Breast CancerUnknown statusIMNNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 1NCT00061867Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate CancerImunon · Prostate CancerCompletedIMNNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 30, 2023ActualPhase 1NCT04852367PanDox: Targeted Doxorubicin in Pancreatic TumoursUniversity of Oxford · Pancreatic Ductal AdenocarcinomaWithdrawnIMNNCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2017ActualPhase 1NCT02181075Targeted Chemotherapy Using Focused Ultrasound for Liver TumoursUniversity of Oxford · Liver TumourCompletedIMNNCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 17 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner